DELRAY BEACH, Fla., July 11, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (Nasdaq:PSID), a leading developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today it has submitted its 510(k) pre-market notification application for its iglucose™ mobile health system for diabetes management to the U.S. Food and Drug Administration (“FDA”). PositiveID’s iglucose is a wireless communication system that facilitates diabetes management by automatically creating electronic logs and journals of blood glucose readings to help ensure patient compliance and data accuracy, as well as to aid in insurance reimbursement.
